Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review.
Andrei-Mihai BălanConstantin BodoleaSebastian Daniel TrancăNatalia HagăuPublished in: Healthcare (Basel, Switzerland) (2023)
Nosocomial pneumonia is one of the most frequent hospital-acquired infections. One of the types of nosocomial pneumonia is ventilator-associated pneumonia, which occurs in endotracheally intubated patients in intensive care units (ICU). Ventilator-associated pneumonia may be caused by multidrug-resistant pathogens, which increase the risk of complications due to the difficulty in treating them. Pneumonia is a respiratory disease that requires targeted antimicrobial treatment initiated as early as possible to have a good outcome. For the therapy to be as specific and started sooner, diagnostic methods have evolved rapidly, becoming quicker and simpler to perform. Polymerase chain reaction (PCR) is a rapid diagnostic technique with numerous advantages compared to classic plate culture-based techniques. Researchers continue to improve diagnostic methods; thus, the newest types of PCR can be performed at the bedside, in the ICU, so-called point of care testing-PCR (POC-PCR). The purpose of this review is to highlight the benefits and drawbacks of PCR-based techniques in managing nosocomial pneumonia.
Keyphrases
- intensive care unit
- acinetobacter baumannii
- multidrug resistant
- real time pcr
- community acquired pneumonia
- respiratory failure
- klebsiella pneumoniae
- healthcare
- ejection fraction
- methicillin resistant staphylococcus aureus
- prognostic factors
- staphylococcus aureus
- emergency department
- stem cells
- escherichia coli
- newly diagnosed
- drug resistant
- quantum dots
- risk factors
- combination therapy
- cancer therapy
- mesenchymal stem cells
- acute care
- single molecule
- smoking cessation
- adverse drug